Abstract
Leishmaniases are a group of neglected diseases endemic in 97 countries, with an annual incidence of approximately 1.5 million cases for the cutaneous form and 300,000 for the visceral form. In Brazil, they represent a serious public health issue, with current therapies often being ineffective, toxic, and difficult to administer, highlighting the need for the identification of new therape…